Sort   by:  
 Page size 
UnknownVirologic and immunologic outcomes of treatment with integrase inhibitors in a real-world setting: The RESPOND cohort consortium.
Not available
S-EPMC7774984 | biostudies-literature
UnknownLarge-scale evaluation of outcomes after a genetic diagnosis in children with severe developmental disorders.
Not available
S-EPMC11736166 | biostudies-literature
UnknownPlasma Human Immunodeficiency Virus 1 RNA and CD4+ T-Cell Counts Are Determinants of Virological Nonsuppression Outcomes With Initial Integrase Inhibitor-Based Regimens: A Prospective RESPOND Cohort Study.
Not available
S-EPMC10893964 | biostudies-literature
UnknownDe novo and inherited TCF20 pathogenic variants are associated with intellectual disability, dysmorphic features, hypotonia, and neurological impairments with similarities to Smith-Magenis syndrome.
Not available
S-EPMC6393995 | biostudies-literature
UnknownIntegrase Strand Transfer Inhibitor Use and Cancer Incidence in a Large Cohort Setting.
Not available
S-EPMC8860165 | biostudies-literature
UnknownViremia Does Not Independently Predict Cardiovascular Disease in People With HIV: A RESPOND Cohort Study.
Not available
S-EPMC11786055 | biostudies-literature
UnknownIncidence of hypertension in people with HIV who are treated with integrase inhibitors versus other antiretroviral regimens in the RESPOND cohort consortium.
Not available
S-EPMC9545382 | biostudies-literature
UnknownCancer burden and risk factors among women with HIV: a multi-regional study from the D:A:D and RESPOND cohort collaborations.
Not available
S-EPMC12818069 | biostudies-literature
UnknownDistinct genetic architectures for syndromic and nonsyndromic congenital heart defects identified by exome sequencing.
Not available
S-EPMC5988037 | biostudies-literature
UnknownGenetic heterogeneity in Cornelia de Lange syndrome (CdLS) and CdLS-like phenotypes with observed and predicted levels of mosaicism.
Not available
S-EPMC4173748 | biostudies-literature
Sort   by:  
 Page size